BRISTOL MYERS SQUIBB CO
BMY
44 insider filings · Latest: Aug 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 2 8:29 PM | David V ElkinsEVP, Chief Financial Officer | Sale | 30,000 | $61.67 | $1.9M | 159,248(D) | View → |
| Apr 1, 2026 | Apr 1 8:32 PM | Elkins David V | Proposed Sale | 30,000 | $61.69 | $1.9M | — | View → |
| Sep 2, 2025 | Sep 2 3:16 PM | Elkins David V | Proposed Sale | 56,000 | $47.30 | $2.6M | — | View → |
| Nov 4, 2024 | Nov 4 4:20 PM | Holzer Phil M | Proposed Sale | 700 | $55.62 | $38.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:22 PM | Bartie Wendy ShortEVP, Corporate Affairs | Option Exercise | 5,883 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Option Exercise | 25,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Grant/Award | 53,061 | — | 31,837(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Grant/Award | 44,898 | — | 26,939(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Option Exercise | 17,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option Exercise | 25,892 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Option Exercise | 24,071 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Grant/Award | 81,633 | — | 48,980(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Grant/Award | 12,578 | — | 7,547(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Option Exercise | 6,191 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Option Exercise | 8,192 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Grant/Award | 16,327 | — | 9,796(D) | View → |
| Mar 10, 2026 | Mar 12 8:16 PM | Cari GallmanEVP, General Counsel | Option Exercise | 6,980 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:16 PM | Cari GallmanEVP, General Counsel | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Ahn Amanda PooleEVP, Chief People Officer | Grant/Award | 38,367 | — | 23,020(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Ahn Amanda PooleEVP, Chief People Officer | Option Exercise | 6,436 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:14 PM | Christopher S. BoernerDirector, Chief Executive Officer | Option Exercise | 71,537 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:14 PM | Christopher S. BoernerDirector, Chief Executive Officer | Grant/Award | 261,225 | — | 156,735(D) | View → |
| Mar 10, 2026 | Mar 12 8:13 PM | David V ElkinsEVP, Chief Financial Officer | Option Exercise | 62,982 | — | 0(D) | View → |